**UNITED
      STATES SECURITIES AND EXCHANGE COMMISSION**


**WASHINGTON,
      D.C. 20549**







**FORM
      10-QSB**







Quarterly
      Report Pursuant to Section 13 or 15 (D) of the Securities Act of
      1934


for
      the
      quarterly period ended: June 30 , 2007





**Commission
      File number:** 333-140320








**GLOBAL
      ADVANCE CORP.**


(Exact
      name of small business issuer as specified in its charter) ****





**Delaware**


(State
      or
      other jurisdiction of Incorporation or organization)





98-0513637 ****


(IRS
      Employee Identification No.)





**Oren
      Rozenberg**


**Global
      Advance Corp.**


Geva
      Street 13/10


Netanya,
      Jerusalem 42319


Tel:
      01197298346829


(Address
      of principal executive offices)





Indicate
      by check mark whether the registrant (1) has filed all reports required to
      be
      filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during
      the preceding 12 months (or for such shorter period that the registrant was
      required to file such reports), and (2) has been subject to such filing
      requirements for the past 90 days. Yes [X] No [ ]





Indicate
      the number of shares outstanding of each of the issuer's classes of common
      stock, as of the latest practicable date:


Common
                  Stock, $0.0001 par value (Class)
              
              (3,025,000
                  Outstanding as of August 13,
                  2007)







**GLOBAL
      ADVANCE CORP.**


**Form
      10-QSB**





**Index**


PagePart
                  I - FINANCIAL INFORMATIONItem
                  1. Financial Statements (Unaudited)
              
              F-1Item
                  2 Management’s Discussion and Analysis or Plan of Operation
              
              3Item
                  3 Control and Procedures
              
              7Part
                  II. OTHER INFORMATIONItem
                  1. Legal Proceedings
              
              8Item
                  2. Changes in Securities
              
              8Item
                  3. Defaults Upon Senior Securities
              
              8Item
                  4. Submission Of Matters To A Vote of Security Holders
              
              8Item
                  5. Other Information
              
              8Item
                  6. Exhibits and Reports on Form 8 -K
              
              9Signatures
              
              10Certifications




2




**Part
      I:**   **Financial
      Information**





**Item
      1.**   **Financial
      Statements**




**GLOBAL
        ADVANCE CORP.**
 **(A
        DEVELOPMENT STAGE COMPANY)**
 **INDEX
        TO INTERIM FINANCIAL STATEMENTS**
 **JUNE
        30, 2007**
 **(UNAUDITED)**
 
 Financial
                  Statements-Balance
                  Sheet as ofJune
                  30, 2007
              
              
              F-2Statements
                  of Operations for the Three Months and Six Months EndedJune
                  30, 2007, and Cumulative from Inception
              
              
              F-3Statements
                  of Cash Flows for the Six Months Ended June 30, 2007,and
                  Cumulative from Inception
              
              
              F-4Notes
                  to Financial Statements June 30, 2007
              
              
              F-5
  F-1
  **GLOBAL
          ADVANCE CORP.** **(A
            DEVELOPMENT STAGE COMPANY)** **BALANCE
              SHEET (NOTE 2)** **AS
                OF JUNE 30, 2007** **(Unaudited)**
  **2007****ASSETS****Current
                    Assets:**Cash
                    in bank
                
                $
                31,007Total
                    current assets
                
                
                31,007**Other
                    Assets:**Patent
                    pending
                
                
                15,560Deferred
                    offering costs
                
                
                33,250Total
                    other assets
                
                
                48,810**Total
                    Assets**
                
                $
                79,817**LIABILITIES
                    AND STOCKHOLDERS' EQUITY****Current
                    Liabilities:**Accrued
                    liabilities
                
                $
                4,750Loans
                    from related parties - Directors and stockholders
                
                
                39,800Total
                    current liabilities
                
                
                44,550Total
                    liabilities
                
                
                44,550**Commitments
                    and Contingencies****Stockholders'
                    Equity:**Common
                    stock, par value $.0001 per share, 50,000,000 sharesauthorized;
                    2,025,000 shares issued and outstanding
                
                
                202Common
                    stock subscribed, par value $.0001 per share, 750,000
                    shares
                
                
                75Additional
                    paid-in capital
                
                
                76,923(Deficit)
                    accumulated during the development stage
                
                
                (41,933
                )Total
                    stockholders' equity
                
                
                35,267**Total
                    Liabilities and Stockholders' Equity**
                
                $
                79,817
  The
        accompanying notes to financial statements
 are
        an
        integral part of this balance sheet.
  F-2
 
 **GLOBAL
          ADVANCE CORP.**
 **(A
          DEVELOPMENT STAGE COMPANY)**
 **STATEMENTS
          OF OPERATIONS (NOTE 2)**
 **FOR
          THE THREE MONTHS AND SIX MONTHS ENDED JUNE 30, 2007,**
 **AND
          CUMULATIVE FROM INCEPTION (OCTOBER 23, 2006)**
 **THROUGH
          JUNE 30, 2007**
 **(Unaudited)**
  **Three
                    Months**
                
                **Six
                    Months****Ended**
                
                **Ended**
                
                **Cumulative****June
                    30,**
                
                **June
                    30,**
                
                **From****2007**
                
                **2007**
                
                **Inception****Revenues**
                
                $
                -
                
                $
                -
                
                $
                -**Expenses:**General
                    and administrative-Legal
                    fees - incorporation
                
                
                -
                
                
                
                
                
                1,500Professional
                    fees
                
                
                13,120
                
                
                29,823
                
                
                33,723Other
                
                
                4,343
                
                
                6,122
                
                
                6,710Total
                    general and administrative expenses
                
                
                17,463
                
                
                35,945
                
                
                41,933**(Loss)
                    from Operations**
                
                
                (17,463
                )
                
                (35,945
                )
                
                (41,933
                )**Other
                    Income (Expense)**
                
                
                -
                
                
                -
                
                
                -**Provision
                    for income taxes**
                
                
                -
                
                
                -
                
                
                -**Net
                    (Loss)**
                
                $
                (17,463
                )
                $
                (35,945
                )
                $
                (41,933
                )**(Loss)
                    Per Common Share:**(Loss)
                    per common share - Basic and Diluted
                
                $
                (0.01
                )
                $
                (0.02
                )**Weighted
                    Average Number of Common Shares****Outstanding
                    - Basic and Diluted**
                
                
                2,016,758
                
                
                2,008,425
  The
        accompanying notes to financial statements are
 an
        integral part of these statements.
  F-3
   **GLOBAL
          ADVANCE CORP.**
 **(A
          DEVELOPMENT STAGE COMPANY)**
 **STATEMENTS
          OF CASH FLOWS (NOTE 2)**
 **FOR
          THE SIX MONTHS ENDED JUNE 30, 2007,**
 **AND
          CUMULATIVE FROM INCEPTION (OCTOBER 23, 2006)**
 **THROUGH
          JUNE 30, 2007**
 **(Unaudited)**
  **Six
                    Months****Ended**
                
                **Cumulative****June
                    30,**
                
                **From****2007**
                
                **Inception****Operating
                    Activities:**Net
                    (loss)
                
                $
                (35,945
                )
                $
                (41,933
                )Adjustments
                    to reconcile net (loss) to net cash(used
                    in) operating activities:Common
                    stock issued for consulting services
                
                
                2,000
                
                
                2,000Changes
                    in net liabilities-Accrued
                    liabilities
                
                
                (7,000
                )
                
                4,750**Net
                    Cash (Used in) Operating Activities**
                
                
                (40,945
                )
                
                (35,183
                )**Investing
                    Activities:**Acquisition
                    and costs of patent pending
                
                
                -
                
                
                (15,560
                )**Net
                    Cash (Used in) Investing Activities**
                
                
                -
                
                
                (15,560
                )**Financing
                    Activities:**Issuance
                    of common stock for cash
                
                
                75,000
                
                
                75,200Deferred
                    offering costs
                
                
                (23,250
                )
                
                (33,250
                )Loans
                    from related parties - Directors and stockholders
                
                
                20,000
                
                
                39,800Loan
                    from third-party entity related to consultant
                
                
                -
                
                
                15,000Repayment
                    of loan from third-party entity related to consultant
                
                
                -
                
                
                (15,000
                )**Net
                    Cash Provided by Financing Activities**
                
                
                71,750
                
                
                81,750**Net
                    Increase in Cash**
                
                
                30,805
                
                
                31,007**Cash
                    - Beginning of Period**
                
                
                202
                
                
                -**Cash
                    - End of Period**
                
                $
                31,007
                
                $
                31,007**Supplemental
                    Disclosure of Cash Flow Information:**Cash
                    paid during the period for:Interest
                
                $
                -
                
                $
                -Income
                    taxes
                
                $
                -
                
                $
                -
  The
        accompanying notes to financial statements are
 an
        integral part of these statements.
 
  F-4
  **GLOBAL
        ADVANCE CORP.**
 **(A
        DEVELOPMENT STAGE COMPANY)**
 **NOTES
        TO FINANCIAL STATEMENTS**
 **JUNE
        30, 2007**
 **(Unaudited)**
  **(1)**  **Summary
        of Significant Accounting Policies**
 
 **** *Basis
        of Presentation and Organization*
 
 Global
        Advance Corp. (“Global Advance” or the “Company”) is a Delaware corporation in
        the development stage and has not commenced operations. The Company was
        incorporated under the laws of the State of Delaware on October 23, 2006.
        The
        business plan of the Company is to develop a commercial application of a
        prototype utilizing the design in a patent pending of a “two-foot operated
        mouse” which is a device intended to provide alternate access to all
        computer-related mouse functionality through the use of one’s feet, rather than
        one’s hands. The Company also intends to enhance the existing prototype, obtain
        approval of its patent application, and manufacture and market the product
        and/or seek third party entities interested in licensing the rights to
        manufacture and market the two-foot operating mouse device. The accompanying
        financial statements of Global Advance were prepared from the accounts of
        the
        Company under the accrual basis of accounting.
 
 The
        Company commenced a capital formation activity to submit a Registration
        Statement on Form SB-2 to the Securities and Exchange Commissions (“SEC”) to
        register and sell in a self-directed offering 1,000,000 shares of newly issued
        common stock at an offering price of $0.10 for proceeds of up to $100,000.
        On
        January 30, 2007, the Company completed the preparation of its registration
        document, and filed it with the SEC. The registration statement was declared
        effective on April 13, 2007. Since April 13, 2007, the Company has received
        stock subscriptions for 750,000 shares of common stock, par value $0.0001
        per
        share, at an offering price of $0.10 per share, and deposited proceeds of
        $75,000. As of June 30, 2007, the Company had not yet issued the common stock
        certificates related to the subscriptions received. The Company intends to
        continue with its capital formation activity until all 1,000,000 shares of
        registered common stock have been subscribed, and total proceeds of $100,000
        received.
  **  *Unaudited
        Interim Financial Statements*
 
 The
        Company’s interim financial statements as of June 30, 2007, and for the periods
        then ended, and cumulative from inception are unaudited. However, in the
        opinion
        of management, the interim financial statements include all adjustments,
        consisting only of normal recurring adjustments, necessary to present fairly
        the
        Company’s financial position as of June 30. 2007, and the results of its
        operations and its cash flows for the periods ended June 30, 2007, and
        cumulative from inception. These results are not necessarily indicative of
        the
        results expected for the calendar year ending December 31, 2007. The
        accompanying financial statements and notes thereto do not reflect all
        disclosures required under accounting principles generally accepted in the
        United States. Refer to the Company’s audited financial statements contained in
        its Registration Statement on Form SB-2 as of December 31, 2006, for additional
        information, including significant accounting policies.
  F-5
  **GLOBAL
          ADVANCE CORP.**
 **(A
          DEVELOPMENT STAGE COMPANY)**
 **NOTES
          TO FINANCIAL STATEMENTS**
 **JUNE
          30, 2007**
 **(Unaudited)**
   *Cash
        and Cash Equivalents*
 
 For
        purposes of reporting within the statement of cash flows, the Company considers
        all cash on hand, cash accounts not subject to withdrawal restrictions or
        penalties, and all highly liquid debt instruments purchased with a maturity
        of
        three months or less to be cash and cash equivalents.
 
 *Revenue
        Recognition*
 
 The
        Company is in the development stage and has yet to realize revenues from
        operations. Once the Company has commenced operations, it will recognize
        revenues when delivery of goods or completion of services has occurred provided
        there is persuasive evidence of an agreement, acceptance has been approved
        by
        its customers, the fee is fixed or determinable based on the completion of
        stated terms and conditions, and collection of any related receivable is
        probable.
  *Loss
        per Common Share*
 
 Basic
        loss per share is computed by dividing the net loss attributable to the common
        stockholders by the weighted average number of shares of common stock
        outstanding during the period. Fully diluted loss per share is computed similar
        to basic loss per share except that the denominator is increased to include
        the
        number of additional common shares that would have been outstanding if the
        potential common shares had been issued and if the additional common shares
        were
        dilutive. There were no dilutive financial instruments issued or outstanding
        for
        the period ended June 30, 2007.
 
 *Income
        Taxes*
 
 The
        Company accounts for income taxes pursuant to SFAS No. 109, *Accounting
        for Income Taxes* (“SFAS
        109”). Under SFAS 109, deferred tax assets and liabilities are determined based
        on temporary differences between the bases of certain assets and liabilities
        for
        income tax and financial reporting purposes. The deferred tax assets and
        liabilities are classified according to the financial statement classification
        of the assets and liabilities generating the differences.
 
 The
        Company maintains a valuation allowance with respect to deferred tax assets.
        The
        Company establishes a valuation allowance based upon the potential likelihood
        of
        realizing the deferred tax asset and taking into consideration the Company’s
        financial position and results of operations for the current period. Future
        realization of the deferred tax benefit depends on the existence of sufficient
        taxable income within the carryforward period under the Federal tax
        laws.
 
 Changes
        in circumstances, such as the Company generating taxable income, could cause
        a
        change in judgment about the realizability of the related deferred tax asset.
        Any change in the valuation allowance will be included in income in the year
        of
        the change in estimate.
 
 F-6
  **GLOBAL
        ADVANCE CORP.**
 **(A
          DEVELOPMENT STAGE COMPANY)**
 **NOTES
          TO FINANCIAL STATEMENTS**
 **JUNE
          30, 2007**
 **(Unaudited)**
 
 *Fair
        Value of Financial Instruments*
 
 The
        Company estimates the fair value of financial instruments using the available
        market information and valuation methods. Considerable judgment is required
        in
        estimating fair value. Accordingly, the estimates of fair value may not be
        indicative of the amounts the Company could realize in a current market
        exchange. As of June 30, 2007, the carrying value of accrued liabilities,
        and
        loans from directors and stockholders approximated fair value due to the
        short-term nature and maturity of these instruments.
  *Patent
        and Intellectual Property*
 
 The
        Company capitalizes the costs associated with obtaining a Patent or other
        intellectual property pertaining to its intended business plan. Such costs
        are
        amortized over the estimated useful lives of the related assets.
 
 *Deferred
        Offering Costs*
 
 The
        Company defers as other assets the direct incremental costs of raising capital
        until such time as the offering is completed. At the time of the completion
        of
        the offering, the costs are charged against the capital raised. Should the
        offering be terminated, deferred offering costs are charged to operations
        during
        the period in which the offering is terminated.
 
 *Concentration
        of Risk*
 
 As
        of
        June 30, 2007, the Company maintained its cash account at one commercial
        bank.
        The balance in the account was not subject to significant risk of
        loss.
 
 **  *Impairment
        of Long-Lived Assets*
 
 The
        Company evaluates the recoverability of long-lived assets and the related
        estimated remaining lives when events or circumstances lead management to
        believe that the carrying value of an asset may not be recoverable. For the
        period ended June 30, 2007, no events or circumstances occurred for which
        an
        evaluation of the recoverability of long-lived assets was required.
 
 *Common
        Stock Registration Expenses*
 
 The
        Company considers incremental costs and expenses related to the registration
        of
        equity securities with the SEC, whether by contractual arrangement as of
        a
        certain date or by demand, to be unrelated to original issuance transactions.
        As
        such, subsequent registration costs and expenses are expensed as
        incurred.
 
 F-7
 **GLOBAL
          ADVANCE CORP.**
 **(A
          DEVELOPMENT STAGE COMPANY)**
 **NOTES
          TO FINANCIAL STATEMENTS**
 **JUNE
          30, 2007**
 **(Unaudited)**
  *Estimates*
 
 The
        financial statements are prepared on the basis of accounting principles
        generally accepted in the United States. The preparation of financial statements
        in conformity with generally accepted accounting principles requires management
        to make estimates and assumptions that affect the reported amounts of assets
        and
        liabilities as of June 30, 2007, and expenses for the periods ended June
        30,
        2007, and cumulative from inception. Actual results could differ from those
        estimates made by management.
 
 **(2)**  **Development
        Stage Activities and Going Concern**
 
 The
        Company is currently in the development stage, and has no operations. The
        business plan of the Company is to develop a commercial application of a
        prototype utilizing the design in a patent pending of a “two-foot operated
        mouse” which is a device intended to provide alternate access to all
        computer-related mouse functionality through the use of one’s feet, rather than
        one’s hands. The Company also intends to enhance the existing prototype, obtain
        approval of its patent application, and manufacture and market the product
        and/or seek third party entities interested in licensing the rights to
        manufacture and market the two-foot operating mouse device.
 
 On
        November 28, 2006, the Company entered into an Invention Assignment Agreement
        with IdeaPlus Ltd., an Israeli company located in Ramat Gan, Israel, whereby
        the
        Company acquired from IdeaPlus Ltd. all of the right, title and interest
        in the
        invention known as the “Two-foot Operated Mouse” for consideration of $10,000.
        Subsequently, the invention became the subject of United States Patent
        Application 11/614,150 which was filed with the United States Patent and
        Trademark Office on December 21, 2006. Currently, the Patent Application
        is
        pending.
 
 The
        Company commenced a capital formation activity to submit a Registration
        Statement on Form SB-2 to the Securities and Exchange Commissions (“SEC”) to
        register and sell in a self-directed offering 1,000,000 shares of newly issued
        common stock at an offering price of $0.10 for proceeds of up to $100,000.
        On
        January 30, 2007, the Company completed the preparation of its registration
        document, and filed it with the SEC. The registration statement was declared
        effective on April 13, 2007. Since April 13, 2007, the Company has received
        stock subscriptions for 750,000 shares of common stock, par value $0.0001
        per
        share, at an offering price of $0.10 per share, and deposited proceeds of
        $75,000. As of June 30, 2007, the Company had not yet issued the common stock
        certificates related to the subscriptions received. The Company intends to
        continue with its capital formation activity until all 1,000,000 shares of
        registered common stock have been subscribed, and total proceeds of $100,000
        received.
 
 The
        accompanying financial statements have been prepared in conformity with
        accounting principles generally accepted in the United States of America,
        which
        contemplate continuation of the Company as a going concern. The Company has
        not
        established any source of revenue to cover its operating costs, and as such,
        has
        incurred an operating loss since inception. Further, as of June 30, 2007,
        the
        cash resources of the Company were insufficient to meet its current business
        plan, and the Company had negative working capital. These and other factors
        raise substantial doubt about the Company’s ability to continue as a going
        concern. The accompanying financial statements do not include any adjustments
        to
        reflect the possible future effects on the recoverability and classification
        of
        assets or the amounts and classification of liabilities that may result from
        the
        possible inability of the Company to continue as a going concern.
  F-8
 **GLOBAL
          ADVANCE CORP.**
 **(A
          DEVELOPMENT STAGE COMPANY)**
 **NOTES
          TO FINANCIAL STATEMENTS**
 **JUNE
          30, 2007**
 **(Unaudited)**
 **(3)**  **Patent
        Pending**
 
 On
        November 28, 2006, the Company entered into an Invention Assignment Agreement
        (the “Invention Agreement”) with IdeaPlus Ltd. (“IdeaPlus”), an Israeli company
        located in Ramat Gan, Israel, whereby the Company acquired from IdeaPlus
        all of
        the right, title and interest in the invention known as the “Two-foot Operated
        Mouse” (the “Invention”) for consideration of $10,000. Under the terms of the
        Invention Agreement, the Company was assigned rights to the Invention free
        of
        any liens, claims, royalties, licenses, security interests or other
        encumbrances. IdeaPlus initially obtained the Invention directly from the
        inventor. Neither IdeaPlus nor the inventor of the Invention is an officer
        or
        director of the Company, or an investor or promoter of such. Subsequently,
        the
        Invention became the subject of United States Patent Application 11/614,150
        which was filed with the United States Patent and Trademark Office on December
        21, 2006. Currently, the Patent Application is pending. The historical cost
        of
        obtaining the Invention and filing for the patent has been capitalized by
        the
        Company, and amounted to $15,560 as of June 30, 2007. If the Patent is granted
        to the Company, the historical cost of the Patent will be amortized over
        its
        useful life, which is estimated to be 20 years.
 
 **(4)**  **Loans
        from Related Parties - Directors and Stockholders**
 
 As
        of
        June 30, 2007, loans from related parties - Directors and stockholders amounted
        to $39,800, and represented working capital advances from two Directors who
        are
        also stockholders of the Company. The loans are unsecured, non-interest bearing,
        and due on demand.
 
 **(5)**  **Common
        Stock**
 
 On
        December 22, 2006, the Company issued 2,000,000 shares of its common stock
        to
        two individuals who are Directors and officers for proceeds of
        $200.
  The
        Company commenced a capital formation activity to submit a Registration
        Statement on Form SB-2 to the Securities and Exchange Commissions (“SEC”) to
        register and sell in a self-directed offering 1,000,000 shares of newly issued
        common stock at an offering price of $0.10 for proceeds of up to $100,000.
        On
        January 30, 2007, the Company completed the preparation of its registration
        document, and filed it with the SEC. The registration statement was declared
        effective on April 13, 2007. Since April 13, 2007, the Company has received
        stock subscriptions for 750,000 shares of common stock, par value $0.0001
        per
        share, at an offering price of $0.10 per share, and deposited proceeds of
        $75,000. As of June 30, 2007, the Company had not yet issued the common stock
        certificates related to the subscriptions received. The Company intends to
        continue with its capital formation activity until all 1,000,000 shares of
        registered common stock have been subscribed, and total proceeds of $100,000
        received. In addition, as of June 30, 2007, the Company had incurred $33,500
        of
        deferred offering costs related to this capital formation activity.
  F-9
 **GLOBAL
          ADVANCE CORP.**
 **(A
          DEVELOPMENT STAGE COMPANY)**
 **NOTES
          TO FINANCIAL STATEMENTS**
 **JUNE
          30, 2007**
 **(Unaudited)**
 **(6)**  **Related
        Party Transactions**
 
 As
        described in Note 4, as of June 30, 2007, the Company owed $39,800 to two
        individuals who are Directors, officers, and principal stockholders of the
        Company for working capital loans.
 
 **(7)**  **Commitments**
 
 The
        Company has a verbal commitment with a third-party consultant to provide
        financial and capital formation services for which the management of the
        Company
        has agreed to pay approximately $5,000 per calendar quarter, plus out-of-pocket
        expenses, commencing in the year 2007. During the period ended December 31,
        2006, the Company borrowed $15,000 from an entity affiliated with this
        consultant for working capital to commence its organizational, patent
        application, and capital formation activities. The amount borrowed was repaid
        before December 31, 2006. For the period ended June 30, 2007, fees amounting
        to
        $18,000 were paid to the third-part consultant.
 
 On
        April
        18, 2007, the Company entered into a Consulting Agreement with Island
        Capital Management, LLC dba Island Stock Transfer (“Island Stock Transfer”)
        for consulting and advisory services. Under the Agreement, the Company
        agreed to pay to Island Stock Transfer initial fees amounting to $4,000 plus
        transaction fees payable as follows: (1) $1,000 due at the time of execution
        of
        the Agreement; and, $1,000 within 60 days; (2) the issuance of 25,000 shares
        of
        the Company’s common stock with a value of $2,000; and (3) transaction fees in
        accordance with the fee schedule for services of Island Stock Transfer. The
        Company also has the right under the Agreement to repurchase the 25,000 shares
        of common stock from Island Stock Transfer for a period of 12 months for
        $10,000. For the three months ended June 30, 2007, the Company paid the initial
        fee of $1,000 for consulting and advisory services, and issued 25,000
        shares of common stock for such services with a value of $2,000.
 
 **(8)**  **Recent
        Accounting Pronouncements**
 
 In
        June
        2006, the FASB issued SFAS Board Interpretation No. 48, “ *Accounting
        for Uncertainty in Income Taxes - an Interpretation of FASB statement No.
        109* ”
(“FIN
        48”), which clarifies the accounting for uncertainty in income taxes recognized
        in an enterprise’s financial statements in accordance with FASB No. 109. The
        interpretation prescribes a recognition threshold and measurement attribute
        for
        the financial statement recognition and measurement of a tax position taken
        or
        expected to be taken in a tax return. This interpretation also provides guidance
        on derecognition, classification, interest and penalties, accounting in interim
        periods, disclosure, and transition. FIN 48 is effective for fiscal years
        beginning after December 15, 2006. Earlier application of the provisions
        of FIN
        48 is encouraged if the enterprise has not yet issued financial statements,
        including interim financial statements, in the period this Interpretation
        is
        adopted. The Company does not expect the adoption of this pronouncement to
        any
        impact on its financial statements.
 
 In
        September 2006, the FASB issued SFAS No. 157, “ *Fair
        Value Measurements* .”
This
        statement defines fair value, establishes a framework for measuring fair
        value
        in generally accepted accounting principles, and expands disclosure about
        fair
        value measurements. This statement applies under other accounting pronouncements
        that require or permit fair value measurement, the FASB having previously
        concluded in those accounting pronouncement that fair value is the relevant
        measurement attribute. This statement does not require any new fair value
        measurements. However, for some entities, the application of the statement
        will
        change current practice. This statement is effective for financial statements
        issued for fiscal years beginning after November 15, 2007, and interim periods
        within those fiscal years. The Company does not expect the adoption of this
        pronouncement to have a material impact on its financial
        statements.
  F-10
 **GLOBAL
          ADVANCE CORP.**
 **(A
          DEVELOPMENT STAGE COMPANY)**
 **NOTES
          TO FINANCIAL STATEMENTS**
 **JUNE
          30, 2007**
 **(Unaudited)**
 In
        September 2006, the FASB issued SFAS No. 158, “ *Employers’
        Accounting for Defined Benefit Pension and Other Postretirement Plans - an
        amendment of FASB Statements No. 87, 88, 106 and 132(R)* .”
This
        statement improves financial reporting by requiring an employer to recognize
        the
        overfunded or underfunded status of a defined benefit postretirement plan
        (other
        than a multi-employer plan) as an asset or liability in its statement of
        financial position and to recognize changes in that funded status in the
        year in
        which the changes occur through comprehensive income of a business entity
        or
        changes in unrestricted net assets for a not-for-profit organization. This
        statement also improves financial reporting by requiring an employer to measure
        the funded status of a plan as of the date of its year-end statement of
        financial position, with limited exceptions. The Company does not expect
        the
        adoption of this pronouncement to have any impact on its financial
        statements.
 
 In
        February 2007, the FASB issued SFAS No. 159, " *The
        Fair Value Option for Financial Assets and Financial Liabilities - Including
        An
        Amendment of FASB Statement No. 115* ,"
        which
        permits entities to measure many financial instruments and certain other
        items
        at fair value that are not currently required to be measured at fair value.
        An
        entity would report unrealized gains and losses on items for which the fair
        value option has been elected in earnings at each subsequent reporting date.
        The
        objective is to improve financial reporting by providing entities with the
        opportunity to mitigate volatility in reported earnings caused by measuring
        related assets and liabilities differently without having to apply complex
        hedge
        accounting provisions. The decision about whether to elect the fair value
        option
        is applied instrument by instrument, with a few exceptions; the decision
        is
        irrevocable; and it is applied only to entire instruments and not to portions
        of
        instruments. SFAS No. 159 requires disclosures that facilitate comparisons
        (a)
        between entities that choose different measurement attributes for similar
        assets
        and liabilities and (b) between assets and liabilities in the financial
        statements of an entity that selects different measurement attributes for
        similar assets and liabilities. SFAS No. 159 is effective for financial
        statements issued for fiscal years beginning after November 15, 2007. Early
        adoption is permitted as of the beginning of a fiscal year provided the entity
        also elects to apply the provisions of SFAS No. 157. Upon implementation,
        an
        entity shall report the effect of the first re-measurement to fair value
        as a
        cumulative-effect adjustment to the opening balance of retained earnings.
        Since
        the provisions of SFAS No. 159 are applied prospectively, any potential impact
        will depend on the instruments selected for fair value measurement at the
        time
        of implementation. The management of the Company does not believe that this
        new
        pronouncement will have a material impact on its financial
        statements.
  F-11
  **GLOBAL
        ADVANCE CORP.**
 **(A
          DEVELOPMENT STAGE COMPANY)**
 **NOTES
          TO FINANCIAL STATEMENTS**
 **JUNE
          30, 2007**
 **(Unaudited)**
  **(9)**  **Income
            Taxes**
 
 The
            provision (benefit) for income taxes for the period ended June 30, 2007,
            was as
            follows (assuming a 15% effective tax rate):
 **Three
                    Months**
                
                **Six
                    Months****Ended**
                
                **Ended****June
                    30,**
                
                **June
                    30,****2007**
                
                **2007**Current
                    Tax Provision:Federal
                    and state-Taxable
                    income
                
                $
                -Total
                    current tax provision
                
                $
                -
                
                $
                -Deferred
                    Tax Provision:Federal
                    and state-Loss
                    carryforwards
                
                $
                2,619
                
                $
                5,393Change
                    in valuation allowance
                
                
                (2,619
                )
                
                (5,393
                )Total
                    deferred tax provision
                
                $
                -
                
                $
                -
  The
          Company had deferred income tax assets as of June 30, 2007, as
          follows:
  **2007**Loss
                  carryforwards
              
              $
              6,290Less
                  - Valuation allowance
              
              
              (6,290
              )Total
                  net deferred tax assets
              
              $
              -
  The
        Company provided a valuation allowance equal to the deferred income tax assets
        for the period ended June 30, 2007, because it is not presently known whether
        future taxable income will be sufficient to utilize the loss
        carryforwards.
 
 As
        of
        June 30, 2007, the Company had approximately $41,933 in tax loss carryforwards
        that can be utilized in future periods to reduce taxable income, and expire
        in
        various years through the year 2027.
  F-12




**Item
      2.****Management’s
      Discussion and Analysis and Plan of Operations.**




USE
      OF
      NAMES





In
      this
      interim report, the terms “Global Advance Corp.”, “Company”, “we”, or “our”,
      unless the context otherwise requires, mean Global Advance Corp. and its
      subsidiaries.





CAUTIONARY
      STATEMENT REGARDING FORWARD-LOOKING STATEMENTS





This
      interim report on Form 10-QSB and other reports that we file with the SEC
      contain statements that are considered forward-looking statements.
      Forward-looking statements give the Company’s current expectations, plans,
      objectives, assumptions or forecasts of future events. All statements other
      than
      statements of current or historical fact contained in this annual report,
      including statements regarding the Company’s future financial position, business
      strategy, budgets, projected costs and plans and objectives of management for
      future operations, are forward-looking statements. In some cases, you can
      identify forward-looking statements by terminology such as “anticipate,”
“estimate,” “plans,” “potential,” “projects,” “ongoing,” “expects,” “management
      believes,” “we believe,” “we intend,” and similar expressions. These statements
      are based on the Company’s current plans and are subject to risks and
      uncertainties, and as such the Company’s actual future activities and results of
      operations may be materially different from those set forth in the forward
      looking statements. Any or all of the forward-looking statements in this annual
      report may turn out to be inaccurate and as such, you should not place undue
      reliance on these forward-looking statements. The Company has based these
      forward-looking statements largely on its current expectations and projections
      about future events and financial trends that it believes may affect its
      financial condition, results of operations, business strategy and financial
      needs. The forward-looking statements can be affected by inaccurate assumptions
      or by known or unknown risks, uncertainties and assumptions due to a number
      of
      factors, including:




·
            dependence
                on key personnel;




·
            competitive
                factors;




·
            degree
                of success of research and development
                programs




·
            the
                operation of our business; and




·
            general
                economic conditions in the United States, Israel and
                China




These
      forward-looking statements speak only as of the date on which they are made,
      and
      except to the extent required by federal securities laws, we undertake no
      obligation to update any forward-looking statements to reflect events or
      circumstances after the date on which the statement is made or to reflect the
      occurrence of unanticipated events. In addition, we cannot assess the impact
      of
      each factor on our business or the extent to which any factor, or combination
      of
      factors, may cause actual results to differ materially from those contained
      in
      any forward-looking statements. All subsequent written and oral forward-looking
      statements attributable to the Company or persons acting on its behalf are
      expressly qualified in their entirety by the cautionary statements contained
      in
      this interim report.





3




**ABOUT
      OUR COMPANY**




We
      are a
      development stage company and currently own the technology for a two-foot
      operated mouse and its prototype. The related technology including the entire
      rights, title and interest in, including a working prototype of, the two-foot
      operated mouse was acquired by us from IdeaPlus Ltd on November 28, 2006.
      Subsequently, on December 21, 2006 we applied for a patent for the “two-foot
      operated mouse”
      (Patent Application No: 11/614,150. The device is intended to assist those
      who
      are unable or prefer to use their feet to operate a computer by replacing a
      standard hand-controlled mouse device with a two-foot operated mouse which
      functions in the same way as a standard device, but is controlled by the user’s
      feet. Our principal business plan is to enhance the existing prototype, and,
      if
      and when we receive a patent for the device, we plan to manufacture and market
      the product and / or seek third party entities interested in licensing the
      rights to manufacture our product.




We
      were
      incorporated in Delaware on October 23, 2006. Our principal offices are located
      at Geva Street 13/10, Netanya, Israel 42319. Our telephone number is
      011972-9-8346829.




For
      the
      year ended December 31, 2006 we had a net loss of $(5,988) and for the six
      months ended June 30 2007 we had a net loss of $(35,945).




**Business
      Summary and Background**





Standard
      computer users use a hand-controlled mouse, a manually operated pointing device.
      Prolonged use of a manual mouse may even cause injuries related to repetitive
      movement and strain. In some cases, where a user prefers or is unable to use
      this device, an alternate possibility is to use a foot-controlled device that
      will enable the user to perform the same operations on the computer. Typically,
      foot operated computer mice include foot-movement sensing pads, foot pedals,
      foot mice that require the use of only one foot, foot track rolls, etc. One
      pedal features a 360-degree pressure-sensitive mechanism, allowing the user
      to
      control both cursor speed and direction with one foot, while the other pedal
      is
      used as a clicking device. Even those products that are used by both feet are
      constructed so that the left and right pedals are equivalent to the left and
      right mouse buttons, providing all the functionality of a hand mouse. The
      present invention relates generally to foot-operated computer mice and more
      specifically, it relates to a two-foot operated mouse for controlling the
      movement of the cursor using both feet. We believe a positive function of a
      foot
      mouse as compared to a hand controlled mouse is that it could increase work
      productivity of the computer user because the user is able to maintain control
      of the cursor without having to take his/her fingers off of the
      keyboard.




A
      primary
      problem presented by conventional foot operated computer mice is that they
      do
      not make use of both feet, resulting in the asymmetric use of one foot over
      another. Another problem with conventional foot operated computer mice is that
      they are expensive. We believe conventional foot operated computer mice limit
      foot movement of the user. That is to say that existing two foot products have
      one foot to control the cursor and one foot to serve as a clicking device.
      Our
      product provides a new two-foot operated computer mouse construction whereby
      the
      user has the ability to fully control the movement of a computer cursor using
      both feet simultaneously.




4




The
      present invention, as it was designed, generally includes a housing containing
      two rollers, two wheels, two shafts, two disks, two electronic sensors, and
      a
      processing chip, with a connecting cable for connecting the two-foot operated
      mouse to a central processing unit. The user places each foot on a roller and
      moves his feet back and forth, turning the rollers. The user can type and
      control the cursor, point and click, and drag and drop without taking hands
      off
      the keyboard. We believe that our foot operated mouse can help users avoid
      carpal tunnel syndrome and mouse induced Repetitive Stress Injuries that are
      typically associated with desktop mice. By having a foot mouse as compared
      to a
      hand mouse, it eliminates stress typically placed on the wrist and elbow
      areas.




The
      company intends to enhance the rough prototype of this invention in order to
      either begin manufacturing and selling the invention, or licensing the
      technology to a third party for them to manufacture it. Partners that we believe
      may have an interest in our product may include any or all computer and/or
      software developers or companies that promote inventions that assist handicapped
      or partially impaired computer users. We have not yet approached or spoken
      with
      any such potential partners or licensees. We also intend to market our product
      to individuals so that they can install the device for personal use in homes
      and
      offices.




Third-party
      manufacturers.




We
      will
      rely on third parties to enhance our current prototype of our two-foot operated
      mouse device and to work with us to manufacture the product. If our
      manufacturing and distribution agreements are not satisfactory, we may not
      be
      able to develop or commercialize our device as planned. In addition, we may
      not
      be able to contract with third parties to manufacture our device in an
      economical manner. Furthermore, third-party manufacturers may not adequately
      perform their obligations, which may impair our competitive position. If a
      manufacturer fails to perform, we could experience significant time delays
      or we
      may be unable to commercialize or continue to market our two-foot operated
      mouse
      device.




**Intellectual
      Property**




On
      November 28, 2006 we acquired from IdeaPlus, a private Israeli based company,
      the entire rights, title and interest in, including a rough working prototype
      of
      the two foot operating mouse. On December 21, 2006 we filed a patent application
      with the United States Patent and Trademark Office.




5


**Competition**




There
      are
      several competitors in the computer mouse sector, some of which include
      Logitech, Kensington and Microsoft all of whom offer mouse and mouse product
      supplies. There are also several companies that offer a two-foot operated mouse
      such as Fentek Industries and Hunter Digital; however, we believe that we are
      unique in that either foot mouse can control both the cursor and the click
      button. We are not aware of any other company that has developed, manufactured
      or marketed a device of a similar nature whereby the two-foot operated mouse
      device offers such flexibility in operational control. Nevertheless, a large
      computer or hardware manufacturer that decides to compete with us would have
      greater access to capital and may be able to produce a product that is less
      expensive than ours or more effective, thus causing any potential sales of
      our
      product to decline.





**Employees**




Other
      than our current officers, Messrs Rozenberg and Steinberger, we have no other
      full time or part-time employees. If and when we begin enhancing the prototype
      for our two-foot operated mouse device and are able to begin manufacturing
      and
      marketing, we may need additional employees for such operations. We do not
      foresee any significant changes in the number of employees or consultants we
      will have over the next twelve months.





**PLAN
      OF OPERATIONS**




**Liquidity,
      Capital Resources and Operations:**




During
      the period ended December 31 2006, and for the first six months ended June
      30
      2007, net cash provided by and ( used in ) operating activities was $5,762
      and
      $(40,945), respectively. The Company incurred net losses of $5,988 and $35,945
      for the period ended December 31 2006 and for the first six months ended June
      30
      2007, respectively. Additionally, at June 30 2007, the Company's Stockholders’
(Deficit) was $41,933, however since April 13, 2007, the Company has received
      stock subscriptions for 750,000 shares of common stock, par value $0.0001 per
      share, at an offering price of $0.10 per share, and deposited proceeds of
      $75,000. As of June 30, 2007, the Company had not yet issued the common stock
      certificates related to the subscriptions received. However as of July 30,
      2007,
      The Company completed its public offering and all 1,000,000 shares of registered
      common stock subscribed for was issued , and total gross proceeds of $100,000
      was received ( including the $75,000 as of June 30 2007 ). In addition, as
      of
      June 30, 2007, the Company had incurred $33,500 of deferred offering costs
      related to this capital formation activity.





6




**Results
      of Operations:**





**For
      the six months ended June 30, 2007**




We
      have
      not generated any revenues since inception. General
      and administrative expenses were $35,945 for the six months ended June 30,
      2007,
      mainly attributable to outside consulting and professional fees incurred for
      the
      related period. Included in this amount is an equity compensation expense in
      the
      amount of $2,000 relating to the issuance of 25,000 shares of common stock
      of
      the Company paid as consulting fees to an independent third party. This amount
      of $35,945 was also the net loss for the period.





We
      have,
      in our history, not generated any income from operations, have incurred
      substantial expenses and have sustained losses. In addition, we expect to
      continue to incur significant operating expenses. We expect our operating
      expenses to increase as a result of our planned expansion.





**Inflation:**




The
      amounts presented in the financial statements do not provide for the effect
      of
      inflation on the Company’s operations or its financial position.





**Off-Balance
      Sheet Arrangements**





We
      do not
      have any off-balance sheet arrangements that have or are reasonably likely
      to
      have a current or future effect on our financial condition, changes in financial
      condition, revenues or expenses, results of operations, liquidity, capital
      expenditures or capital resources that are material to investors.




**Item
      3.**   **Controls
      and Procedures**





Evaluation
      and Disclosure Controls and Procedures




As
      of the
      end of the period covered by this report, our management conducted an
      evaluation, under the supervision and with the participation of our chief
      executive officer and chief financial officer of the effectiveness of our
      disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e)
      under the Securities Exchange Act of 1934). Based on this evaluation, the
      officers concluded that our disclosure controls and procedures are effective
      to
      ensure that information required to be disclosed by our company in reports
      that
      we file or submit under the Securities Exchange Act of 1934 is recorded,
      processed, summarized and reported within the time periods specified in
      Commission rules and forms.




7




**Changes
      in Internal Controls over Financial Reporting**





Based
      on
      their evaluation as of the end of the period covered by this quarterly report
      on
      Form 10-QSB, our principal executive officer and principal financial officer
      concluded that our disclosure controls and procedures, as defined in Rule
      13a-15(e) promulgated under the Securities Exchange Act of 1924, were effective
      in design and operation. There have been no changes in our system of internal
      control over financial reporting in connection with the evaluation by our
      principal executive officer and principal financial officer during our most
      recent fiscal quarter that have materially affected, or are reasonably likely
      to
      materially affect, our internal control over financial reporting.




**Part
      II. Other Information**





**Item
      1.**   **Legal
      Proceedings** .





Other
      than as set forth herein, we are not aware of any pending or threatened
      litigation against us that we expect will have a material adverse effect on
      our
      business, financial condition, liquidity, or operating results. However, legal
      claims are inherently uncertain and we cannot assure you that we will not be
      adversely affected in the future by legal proceedings.




**Item
      2.**   **Changes
      In Securities**





None





**Item
      3.**  **Defaults
      Upon Senior Securities**





None





**Item
      4.**  **Submission
      of Matters To A Vote Of Security Holders**





None




**Item
      5.**  **Other
      Information**





None




8





**Item
      6.**  **Exhibits**





a.  Exhibits:




EXHIBITNUMBER
            
            DESCRIPTION3.1(1)
            
            Articles
                of Incorporation of the Company3.2
                (1)
            
            By-Laws
                of the Company3.3
                (1)
            
            Form
                of Common Stock Certificate of the Company10.1
                (1)
            
            Acquisition
                of Patent/Technology rights to Global Advance
                Corporation





(1)
            incorporated
                by reference , SB2 registration statement .




9




**Signatures**





Pursuant
      to the requirements of Section 13 or 15(d) of the *Securities
      Exchange Act of 1934* ,
      the
      Registrant has duly caused this report to be signed on its behalf by the
      undersigned, thereunto duly authorized on this 13 th day of
      August 2007.


**GLOBAL
                ADVANCE CORP.**
              (Registrant)By:Oren
                RozenbergPresident
                and Chief Executive Officer




Pursuant
      to the requirements of the Securities Exchange Act of 1934, this report has
      been
      signed below by the following persons on behalf of the registrant and in the
      capacities and on the dates indicated:




**Signature**
            
            **Title**
            
            **Date**/s/
                Oren Rosenberg
            
            President,
                CEO and Director
            
            August
                13 , 2007Oren
                Rozenberg/s/
              Judah SteinbergerJudah
                Steinberger
            
            Chief
                Accounting (Financial) Officer
            
            August
                13 , 2007




10